The correlations between anti-factor Xa activity values and PT/APTT at peak and trough times in patients with venous thromboembolism using high dose of apixaban

被引：0
|
作者：
Ono, R. [1 ]
Fukushima, K. [1 ]
Yamazaki, T. [1 ]
Takahashi, H. [1 ]
Hori, Y. [1 ]
机构：
[1] Matsudo City Gen Hosp, Chiba, Japan
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2406 / 2406
页数：1
相关论文
共 19 条
  • [1] The Correlations Between Anti-Factor Xa Activity Values and Pt-inr/aptt at Peak and Trough Times in Patients on Edoxaban Therapy
    Ono, Ryohei
    Fukushima, Kenichi
    Hori, Yasuhiko
    Takahashi, Hidehisa
    Yamashita, Daichi
    Nishimura, Kaazutaka
    [J]. CIRCULATION, 2018, 138
  • [2] Anti-factor Xa Activity Value At Peak And Trough Times In High Risk Patients With Venous Thromboembolism On Apixaban Therapy
    Ono, Ryohei
    Fukushima, Kenichi
    Yamazaki, Tatsuro
    Takahashi, Hidehisa
    Hori, Yasuhiko
    [J]. CIRCULATION, 2019, 140
  • [3] The distribution of anti-factor Xa activity value, PT and APTT at peak and trough times in patients with direct anti-factor Xa inhibitors
    Ono, R.
    Fukushima, K.
    Yamazaki, T.
    Takahashi, H.
    Hori, Y.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 3368 - 3368
  • [4] THE CORRELATIONS BETWEEN ANTI-FACTOR XA ACTIVITY VALUES AND PROTHROMBIN TIME/ACTIVATED PARTIAL THROMBOPLASTIN TIME AT PEAK AND TROUGH TIMES IN PATIENTS ON DIRECT ORAL ANTICOAGULANTS THERAPY
    Ono, Ryohei
    Fukushima, Kenichi
    Yamashita, Daichi
    Takahashi, Hidehisa
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2107 - 2107
  • [5] PLASMA TROUGH AND PEAK LEVELS OF APIXABAN MEASURED WITH ANTI-FACTOR XA ASSAYS IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS
    Han, Jin-Yeong
    Kwak, Min-Sun
    Shim, Jae-Ryong
    Woo, Kwang-Sook
    Park, Jong-Sung
    [J]. INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 72 - 72
  • [6] Assessment of anti-factor Xa activity of enoxaparin for venous thromboembolism prophylaxis in morbidly obese surgical patients
    Al Otaib, Nouf
    Bootah, Zohour
    Al Ammari, Maha A.
    Aldebasi, Tariq M.
    Alkatheri, Abdulmalik M.
    Al Harbi, Shmeylan A.
    AbuRuz, Salah M.
    AlBekairy, Abdulkareem M.
    [J]. ANNALS OF THORACIC MEDICINE, 2017, 12 (03) : 199 - 203
  • [7] Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma
    Ko, Ara
    Harada, Megan Y.
    Barmparas, Galinos
    Chung, Kevin
    Mason, Russell
    Yim, Dorothy A.
    Dhillon, Navpreet
    Margulies, Daniel R.
    Gewertz, Bruce L.
    Ley, Eric J.
    [J]. JAMA SURGERY, 2016, 151 (11) : 1006 - 1013
  • [8] Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients
    Droege, Molly E.
    Mueller, Eric W.
    Besl, Kelly M.
    Lemmink, Jennifer A.
    Kramer, Elizabeth A.
    Athota, Krishna P.
    Droege, Christopher A.
    Ernst, Neil E.
    Keegan, Shaun P.
    Lutomski, Dave M.
    Hanseman, Dennis J.
    Robinson, Bryce R. H.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 76 (02): : 450 - 456
  • [9] Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
    Dibiasi, Christoph
    Gratz, Johannes
    Wiegele, Marion
    Baierl, Andreas
    Schaden, Eva
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [10] Monitoring Low Molecular Weight Heparins at Therapeutic Levels: Dose-Responses of, and Correlations and Differences between aPTT, Anti-Factor Xa and Thrombin Generation Assays
    Thomas, Owain
    Lybeck, Emanuel
    Strandberg, Karin
    Tynngard, Nahreen
    Schott, Ulf
    [J]. PLOS ONE, 2015, 10 (01):
12